Stay updated on CAB-ROR2-ADC: Phase 1/2 Clinical Trial

Sign up to get notified when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The clinical trial record is now available, with details on the study design, eligibility criteria, treatments, outcomes, locations, and completion status.
    Difference
    76%
    Check dated 2026-11-08T13:31:39.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.2 to v3.8.0; the 403 error page otherwise remains unchanged.
    Difference
    0.2%
    Check dated 2026-11-01T14:45:21.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The clinical trial page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-25T15:33:17.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T16:19:48.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T15:58:10.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with the standard 403 layout, replacing the study content. This indicates restricted access to the NCT03504488 record.
    Difference
    18%
    Check dated 2026-09-20T20:58:27.000Z thumbnail image

Stay in the know with updates to CAB-ROR2-ADC: Phase 1/2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.